Septerna, Inc. (SEPN)
26.07
-1.31
(-4.78%)
USD |
NASDAQ |
Jan 16, 16:00
26.06
0.00 (0.00%)
After-Hours: 20:00
Septerna EPS Diluted (Quarterly): 0.1792 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.875 |
| Altimmune, Inc. | -0.2126 |
| Arcturus Therapeutics Holdings, Inc. | -0.4946 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Viking Therapeutics, Inc. | -0.8083 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 8.173M |
| Revenue (Quarterly) | 21.50M |
| Total Expenses (Quarterly) | 13.32M |
| Enterprise Value | 717.03M |
| Gross Profit Margin (Quarterly) | 98.14% |
| Profit Margin (Quarterly) | 38.02% |
| Earnings Yield | -5.79% |
| Normalized Earnings Yield | -5.793 |